A deeper understanding of the tissue specificity and kinetic properties of the HIF-1α–MST1/2–Caspase network will provide a critical theoretical foundation for developing precision therapeutic strategies for CC. The gene discussed is HIF1A; the disease is cholangiocarcinoma.